Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

TRITON2: Rucaparib for metastatic castration-resistant prostate cancer

Prof Ray McDermott - St. Vincents University Hospital, Dublin, Republic of Ireland
TRITON2: Rucaparib for metastatic castration-resistant prostate cancer ( Prof Ray McDermott - St. Vincents University Hospital, Dublin, Republic of Ireland )
7 Oct 2019

Lutetium-177 PSMA scanning for prostate cancer

Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA
Lutetium-177 PSMA scanning for prostate cancer ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )
7 Oct 2019

Highlights from ESMO 2019

Prof Josep Tabernero - ESMO President
Highlights from ESMO 2019 ( Prof Josep Tabernero - ESMO President )
4 Oct 2019

Optimal timing of radiotherapy following radical prostatectomy

Prof Chris Parker - The Royal Marsden Hospital, London, UK
Optimal timing of radiotherapy following radical prostatectomy ( Prof Chris Parker - The Royal Marsden Hospital, London, UK )
4 Oct 2019

Prostate cancer updates: Advances in precision medicine and PARP inhibitors

Prof Karim Fizazi, Dr Joaquin Mateo, Dr Shahneen Sandhu and Prof Bertrand Tombal
Prostate cancer updates: Advances in precision medicine and PARP inhibitors ( Prof Karim Fizazi, Dr Joaquin Mateo, Dr Shahneen Sandhu and Prof Bertrand Tombal )
2 Oct 2019

Role of molecular diagnostics in prostate cancer

Dr Elena Castro and Dr Shahneen Sandhu
Role of molecular diagnostics in prostate cancer ( Dr Elena Castro and Dr Shahneen Sandhu )
2 Oct 2019

IMvigor130: Immunotherapy added to chemotherapy in metastatic urothelial cancer

Dr Enrique Grande - Hospital MD Anderson Cancer Center Madrid, Madrid, Spain
IMvigor130: Immunotherapy added to chemotherapy in metastatic urothelial cancer ( Dr Enrique Grande - Hospital MD Anderson Cancer Center Madrid, Madrid, Spain )
30 Sep 2019

Atezolizumab added to chemotherapy prolongs progression free survival in bladder cancer

Dr Enrique Grande - Hospital MD Anderson Cancer Center Madrid, Madrid, Spain
Atezolizumab added to chemotherapy prolongs progression free survival in bladder cancer ( Dr Enrique Grande - Hospital MD Anderson Cancer Center Madrid, Madrid, Spain )
30 Sep 2019

Comment: Immunotherapy plus chemotherapy in bladder cancer

Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain
Comment: Immunotherapy plus chemotherapy in bladder cancer ( Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain )
30 Sep 2019

Comment: PARP inhibitors for advanced prostate cancer

Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain
Comment: PARP inhibitors for advanced prostate cancer ( Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain )
30 Sep 2019

PARP inhibitor olaparib slows progression of advanced prostate cancer

Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago, USA
PARP inhibitor olaparib slows progression of advanced prostate cancer ( Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago, USA )
30 Sep 2019

Implementing national cancer control plans

Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation